Serum antistreptolysin 0 (ASO) activity is usually due to antibody. However, a second mechanism involves inhibition of streptolysin by cholesterol. The latter has been recorded in patients with jaundice (Badin et al., 1962) , in nephrosis (Stollerman, 1954) , and in patients with staphylococcal infections (Watson and Kerr, 1975) . The latex particle test has been thought to give positive results only with antibody but we have shown that false-positive results can arise (Watson et al., 1977) . Activity associated with cholesterol can be removed by precipitating the prebeta-and beta-lipoprotein fractions with 10% dextran sulphate. This activity, which we have labelled antistreptolysin factor (ASF), results from alterations of lipoprotein molecules from the action of cholesterol esterase (Watson and Kerr, 1976 Rantz and Randall (1945) was employed. Serum dilutions in 0 05-ml volumes were placed in round bottomed well plates. Dilutions were made in buffered saline (pH 6 5) containing 8 42 g of NaH2PO4 2H20, 8 95 g of Na2HPO4 12H20, and 4-25 g of NaCi per litre. Streptolysin 0 was added in 0 025-ml volumes containing 1-0 unit/ml and trays were incubated for 15 minutes at 370C. Washed human red cells, 5 % concentration, were added in 0 025-ml amounts and plates were reincubated for a further 45 minutes. End points were taken as 50% haemolysis.
POLYENE ANTIBIOTICS
Amphotericin B was dissolved in sterile distilled water at a concentration of 6250 units/ml. This stock solution was further diluted by adding one part to three parts of phosphate buffered saline (pH 6 7). This resulted in a fine precipitate of amphotericin, but this did not interfere with subsequent investigations.
PREPARATION OF ANTISTREPTOLYSIN FACTOR (ASF)
ASF activity was produced by growing Staphylococcus aureus (NCTC strain 7121, Wood 46 strain) in 10 ml of a 60/40 v/v mixture of sterile horse serum and brain heart infusion broth at 370C for four days with continuous shaking. After removing organisms by centrifugation the lipoprotein fraction was precipitated by adding 0-02 ml of 10% dextran sulphate and 0-1 ml of M CaCl2 to each millitre of supernatant fluid. The precipitate was removed after standing overnight at 4-00C, redissolved in distilled water, and dialysed against running tap water for 18 hours.
Lipoproteins were precipitated from latex-positive and latex-negative sera in the same way, a procedure which does not affect antibody titre. All activity in latex-positive sera was in the antibody-containing supernatant fraction whereas activity in latex-negative sera was found in the lipoprotein fraction.
OPTIMUM CONCENTRATION OF AMPHOTERICIN B
The optimum amount of amphotericin B needed to inhibit ASF activity was determined in a series of chequer board type titrations of ASF prepared from horse serum. Dilutions of amphotericin and ASF were reacted at 4-0'C for 10 minutes before the addition of streptolysin solution. We have shown previously that binding of exposed cholesterol molecules in lipoprotein fragments to streptolysin is almost instantaneous. Binding of amphotericin is equally quick. Inhibition of ASF activity is shown in Table 2 for one particular experiment. During an investigation of the mechanisms of non-antibody inhibition of streptolysin 0 activity we found that antistreptolysin titres greater than 200 Todd units/ml were common, but such sera give negative latex tests. We have found these in some patients with rheumatoid arthritis, in staphylococcal infection, in one patient with brucellosis, and in another with Bacteroides fragilis infection (Watson and Kerr, 1975) . In all of these the activity is in the lipoprotein fraction and is removed with 10% dextran sulphate. We have also shown that similar activity is generated in sera incubated with Staph. aureus or Pseudomonas aeruginosa strains (Watson and Kerr, 1976) . Here the mechanism involves cholesterol esterase production, possibly in association with proteolytic enzyme action. This results in the formation of peptide fractions of prebeta-and beta-lipoproteins with molecular weights between 25 000 and 100 000 where the attached cholesterol molecules are spatially orientated so as to be capable of binding to streptolysin. The low level of ASF activity in normal sera seems to be due to this mechanism and probably reflects endogenous esterase function concerned in normal catabolic turnover of lipoproteins. Raised ASF serum levels may then be due to increased endogenous esterase activity or, possibly, as in the case of staphylococcal infection, to exogenous esterase. The former situaion can arise when binding of toxin-for example, streptolysin 0 or other oxygen-labile related haemolysins-to the cholesterol moiety of lipoprotein peptide fragments results in a feed-back mechanism to increase esterase production. We believe the evidence suggests that lipoprotein peptide cholesterol plays a role as a defence mechanism against the action of such toxins and that this is available before antibody formation gets under way.
Our procedures to differentiate ASO from ASF activity in serum lead us to believe that many reports of raised antistreptolysin titres are wrongly interpreted as being due to antibody, and therefore suggestive of streptococcal infection, when in fact they are due to ASF. It seems necessary to distinguish between them. Probably earlier reports of raised antistreptolysin activity in rheumatoid disease 
